Clinical Trial Update: Effect of Proton Pump Inhibitor on Residual Platelet Reactivity After Clopidogrel in Homogenous Genetic Strata [Phase 4]

View source ↗

Summary

An update on a Phase 4 clinical trial evaluating whether proton pump inhibitors influence residual platelet reactivity in patients taking clopidogrel after coro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• CLOPIDOGREL (CLOPIDOGREL)
• Proton Pump Inhibitor (proton pump inhibitor)

Snippet

Sponsor: Università degli Studi di Ferrara | Conditions: Coronary Stenting | Phase 4 | Status: UNKNOWN